☰

Chengliang Zhu - Publications

Affiliations: 
University of Nevada at Reno, Reno, NV, United States 
Area:
physical organic chemistry
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2025 Ding B, Hu J, Zhang R, Shou B, Chen M, Jiang L, Yuan M, Yang B, He Q, Cao J, Zhu CL. Solid-Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery. Angewandte Chemie (International Ed. in English). e202424118. PMID 40432221 DOI: 10.1002/anie.202424118  0.461
2024 Ding B, Lu L, Hu J, Zhang R, Wang F, Zhou Z, Lin Y, Pan C, Zhou Y, Yang B, Zhu CL, Zhou C, Cao J. Identification and validation of WDR5 WIN-site ligands via DNA-encoded chemical library screening. Bioorganic Chemistry. 154: 107948. PMID 39616835 DOI: 10.1016/j.bioorg.2024.107948  0.451
2024 Kadier K, Niu T, Ding B, Chen B, Qi X, Chen D, Cheng X, Fang Y, Zhou J, Zhao W, Liu Z, Yuan Y, Zhou Z, Dong X, Yang B, ... ... Zhu CL, et al. PROTAC-Mediated HDAC7 Protein Degradation Unveils Its Deacetylase-Independent Proinflammatory Function in Macrophages. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2309459. PMID 39049738 DOI: 10.1002/advs.202309459  0.466
2024 Zhang Y, Tong L, Yan F, Huang P, Zhu CL, Pan C. Design, synthesis, and antitumor activity evaluation of potent fourth-generation EGFR inhibitors for treatment of Osimertinib resistant non-small cell lung cancer (NSCLC). Bioorganic Chemistry. 147: 107394. PMID 38691906 DOI: 10.1016/j.bioorg.2024.107394  0.44
2024 Peng TW, Ma QF, Li J, Wang X, Zhang CH, Ma J, Li JY, Wang W, Zhu CL, Liu XH. HBV promotes its replication by up-regulating RAD51C gene expression. Scientific Reports. 14: 2607. PMID 38297111 DOI: 10.1038/s41598-024-53047-7  0.472
2023 Yang LJ, Wu W, Jiang WR, Zhu CL, Yao ZH. Upregulation of RasGRF1 ameliorates spatial cognitive dysfunction in mice after chronic cerebral hypoperfusion. Aging. 15. PMID 37053022 DOI: 10.18632/aging.204654  0.417
2023 Rao Z, Li K, Hong J, Chen D, Ding B, Jiang L, Qi X, Hu J, Yang B, He Q, Dong X, Cao J, Zhu CL. A practical "preTACs-cytoblot" platform accelerates the streamlined development of PROTAC-based protein degraders. European Journal of Medicinal Chemistry. 251: 115248. PMID 36905918 DOI: 10.1016/j.ejmech.2023.115248  0.47
2022 Ma JE, Ma QF, Wang W, Zeng Y, Cui XH, Wang GL, Liu SY, Wang Z, Xiao X, Xia ZN, Zhu HC, Zhu CL. Analysis of Common Respiratory Infected Pathogens in 3100 Children after the Coronavirus Disease 2019 Pandemic. Current Medical Science. PMID 36184728 DOI: 10.1007/s11596-022-2635-z  0.414
2022 Zhu CL, Luo X, Tian T, Rao Z, Wang H, Zhou Z, Mi T, Chen D, Xu Y, Wu Y, Che J, Zhou Y, Li J, Dong X. Structure-based rational design enables efficient discovery of a new selective and potent AKT PROTAC degrader. European Journal of Medicinal Chemistry. 238: 114459. PMID 35635954 DOI: 10.1016/j.ejmech.2022.114459  0.474
2021 Niu T, Li K, Jiang L, Zhou Z, Hong J, Chen X, Dong X, He Q, Cao J, Yang B, Zhu CL. Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor. European Journal of Medicinal Chemistry. 228: 114012. PMID 34864331 DOI: 10.1016/j.ejmech.2021.114012  0.457
2020 Huang JT, Ran RX, Lv ZH, Feng LN, Ran CY, Tong YQ, Li D, Su HW, Zhu CL, Qiu SL, Yang J, Xiao MY, Liu MJ, Yang YT, Liu SM, et al. Chronological Changes of Viral Shedding in Adult Inpatients with COVID-19 in Wuhan, China. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32445580 DOI: 10.1093/cid/ciaa631  0.431
2020 Han H, Yang L, Liu R, Liu F, Wu KL, Li J, Liu XH, Zhu CL. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clinical Chemistry and Laboratory Medicine. PMID 32172226 DOI: 10.1515/cclm-2020-0188  0.433
2020 Kosciuk T, Price IR, Zhang X, Zhu C, Johnson KN, Zhang S, Halaby SL, Komaniecki GP, Yang M, DeHart CJ, Thomas PM, Kelleher NL, Christopher Fromme J, Lin H. NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle. Nature Communications. 11: 1067. PMID 32103017 DOI: 10.1038/S41467-020-14893-X  0.453
2020 Niu Z, Zhang P, Li D, Zhu C, Feng L, Xiong G, Song N, Tang P, Liu F. Association of Apolipoprotein E Polymorphisms with White Matter Lesions and Brain Atrophy. Psychiatry Investigation. PMID 32000479 DOI: 10.30773/pi.2019.0090  0.415
2019 Son SI, Cao J, Zhu CL, Miller SP, Lin H. Activity-Guided Design of HDAC11-Specific Inhibitors. Acs Chemical Biology. PMID 31264832 DOI: 10.1021/Acschembio.9B00292  0.469
2019 Li H, Shen SJ, Zhu CL, Xu H. Direct Intermolecular Anti-Markovnikov Hydroazidation of Unactivated Olefins. Journal of the American Chemical Society. PMID 31070901 DOI: 10.1021/Jacs.9B04381  0.465
2018 Zhou F, Zhu CL, Niu ZL, Xu FX, Song H, Liu XH. Influenza A virus inhibits influenza virus replication by inducing IL-37. Journal of Clinical Laboratory Analysis. e22638. PMID 30098064 DOI: 10.1002/jcla.22638  0.439
2018 Li H, Shen SJ, Zhu CL, Xu H. Enantioselective Synthesis of Oseltamivir Phosphate (Tamiflu) via the Iron-Catalyzed Stereoselective Olefin Diazidation. Journal of the American Chemical Society. PMID 30040881 DOI: 10.1021/Jacs.8B06900  0.494
2018 Zhu CL, Wang C, Qin QX, Yruegas S, Martin CD, Xu H. Iron(II)-Catalyzed Azidotrifluoromethylation of Olefins and N-Heterocycles for Expedient Vicinal Trifluoromethyl Amine Synthesis. Acs Catalysis. 8: 5032-5037. PMID 29938121 DOI: 10.1021/Acscatal.8B01253  0.503
2018 Shen SJ, Zhu CL, Lu DF, Xu H. Iron-Catalyzed Direct Olefin Diazidation via Peroxyester Activation Promoted by Nitrogen-Based Ligands. Acs Catalysis. 8: 4473-4482. PMID 29785320 DOI: 10.1021/Acscatal.8B00821  0.497
2016 Zhu CL, Lu DF, Sears JD, Jia ZX, Xu H. Practical Synthetic Procedures for the Iron-Catalyzed Intermolecular Olefin Aminohydroxylation Using Functionalized Hydroxylamines. Synthesis. 48: 3031-3041. PMID 28090124 DOI: 10.1055/S-0035-1562515  0.484
2016 Lu DF, Zhu CL, Sears JD, Xu H. Iron(II) Catalyzed Intermolecular Aminofluorination of Unfunctionalized Olefins Using Fluoride Ion. Journal of the American Chemical Society. PMID 27529196 DOI: 10.1021/Jacs.6B07221  0.49
2015 Zhu CL, Zhang YQ, Yuan YA, Xu H. Copper-Catalyzed Aerobic C-H Trifluoromethylation of Phenanthrolines. Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry. 26: 345-349. PMID 26855477 DOI: 10.1055/S-0034-1379319  0.438
2015 Zhu CL, Tian JS, Gu ZY, Xing GW, Xu H. Iron(II)-catalyzed asymmetric intramolecular olefin aminochlorination using chloride ion. Chemical Science (Royal Society of Chemistry : 2010). 6: 3044-3050. PMID 26807211 DOI: 10.1039/C5Sc00221D  0.481
2015 Tian JS, Zhu CL, Chen YR, Xu H. Iron-Catalyzed Diastereoselective Intramolecular Olefin Aminobromination with Bromide Ion. Synthesis. 47: 1709-1715. PMID 26806984 DOI: 10.1055/S-0034-1378719  0.491
2015 Yuan CH, Sun XM, Zhu CL, Liu SP, Wu L, Chen H, Feng MH, Wu K, Wang FB. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells. Oncotarget. PMID 26451607 DOI: 10.18632/oncotarget.5171  0.459
2015 Zhu CL, Cheng DZ, Liu F, Yan XH, Wu KL, Wang FB, Liu XH. Hepatitis B virus upregulates the expression of kinesin family member 4A. Molecular Medicine Reports. 12: 3503-7. PMID 25998931 DOI: 10.3892/mmr.2015.3792  0.472
2014 Zhu CL, Gao GS. miR-200a overexpression in advanced ovarian carcinomas as a prognostic indicator. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 8595-601. PMID 25374174 DOI: 10.7314/APJCP.2014.15.20.8595  0.412
2014 Lu DF, Zhu CL, Jia ZX, Xu H. Iron(II)-catalyzed intermolecular amino-oxygenation of olefins through the N-O bond cleavage of functionalized hydroxylamines. Journal of the American Chemical Society. 136: 13186-9. PMID 25166591 DOI: 10.1021/Ja508057U  0.47
2014 Lu DF, Liu GS, Zhu CL, Yuan B, Xu H. Iron(II)-catalyzed intramolecular olefin aminofluorination. Organic Letters. 16: 2912-5. PMID 24829034 DOI: 10.1021/Ol501051P  0.492
2014 Zhou J, Xu XZ, Hu YR, Hu AR, Zhu CL, Gao GS. Cryptotanshinone induces inhibition of breast tumor growth by cytotoxic CD4+ T cells through the JAK2/STAT4/ perforin pathway. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 2439-45. PMID 24761844 DOI: 10.7314/APJCP.2014.15.6.2439  0.442
2014 Wei XS, Wei CD, Tong YQ, Zhu CL, Zhang PA. Single nucleotide polymorphisms of toll-like receptor 7 and toll-like receptor 9 in hepatitis C virus infection patients from central China. Yonsei Medical Journal. 55: 428-34. PMID 24532514 DOI: 10.3349/ymj.2014.55.2.428  0.441
2014 Yuan CH, Yang XQ, Zhu CL, Liu SP, Wang BC, Wang FB. Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 265-71. PMID 24528037 DOI: 10.7314/APJCP.2014.15.1.265  0.447
2013 Pan F, Cheng YX, Tao FH, Zhu CL, Li ZH, Tao HY, He B, Yu L, Liu Y, Tang H. [Protective effect of tacrolimus postconditioning on oxidative stress injury provoked by spinal cord ischemia-reperfusion in rats]. Zhonghua Yi Xue Za Zhi. 93: 3796-800. PMID 24548402 DOI: 10.3760/cma.j.issn.0376-2491.2013.47.020  0.435
2013 Pan F, Cheng YX, Zhu CL, Tao FH, Li ZH, Tao HY, He B, Yu L, Ji P, Tang H. Tacolimus postconditioning alleviates apoptotic cell death in rats after spinal cord ischemia-reperfusion injury via up-regulating protein-serine-threonine kinases phosphorylation. Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban. 33: 852-6. PMID 24337847 DOI: 10.1007/s11596-013-1210-z  0.433
2013 Yan HD, Jiang FR, Zhu CL, Gao GS, Weng PJ, Hu AR, Xu CF, Hu YR, Sheng JF. [Liver histopathological features influencing HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B responding to Peg-IFN treatment]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 21: 340-4. PMID 24025133 DOI: 10.3760/cma.j.issn.1007-3418.2013.05.007  0.45
2011 Liu XH, Zhou X, Zhu CL, Song H, Liu F. [Effects of HCV core protein on the expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 19: 751-4. PMID 22409847 DOI: 10.3760/cma.j.issn.1007-3418.2011.10.008  0.433
2011 Wang FB, Zhu CL, Liu X, Gao GS. HBV inhibits apoB production via the suppression of MTP expression. Lipids in Health and Disease. 10: 207. PMID 22074108 DOI: 10.1186/1476-511X-10-207  0.466
2011 Gu JG, Zhu CL, Cheng DZ, Xie Y, Liu F, Zhou X. Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication. Lipids in Health and Disease. 10: 154. PMID 21875437 DOI: 10.1186/1476-511X-10-154  0.463
2006 Pan F, Chen AM, Guo FJ, Zhu CL. [Effect of tacrolimus on apoptosis and expression of heat shock protein 70 after acute spinal cord injury in rats]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 44: 1708-12. PMID 17359722  0.432
Show low-probability matches.